Department of Pediatrics, College of Medicine, Qassim University, Qassim, 51452, Saudi Arabia.
Department of Pediatrics, College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia.
Antimicrob Resist Infect Control. 2021 Jan 22;10(1):19. doi: 10.1186/s13756-021-00888-w.
Stenotrophomonas maltophilia (S. maltophilia) is an opportunistic and nosocomial pathogen that can cause an invasive and fatal infection, particularly in hospitalized and immunocompromised patients. However, little is known about the impact of S. maltophilia bacteremia in pediatric patients. Therefore, we aimed to identify risk factors for mortality, antibiotics susceptibility to S. maltophilia, and mortality rates in pediatric patients with S. maltophilia bacteremia.
We conducted a retrospective cohort study by identifying all S. maltophilia positive blood cultures in the microbiology laboratory database between January 2007 and December 2018 from hospitalized pediatric patients (age 1-14 years). After identifying patients with S. maltophilia bacteremia, medical charts were reviewed for demographics, clinical data, and outcomes within seven days of bacteremia diagnosis. Risk factors associated with mortality in S. maltophilia bacteremia patients were determined using univariate and multivariate analyses.
Sixty-eight pediatric patients with S. maltophilia bacteremia were identified. All infections were nosocomial infections, and (88.2%) bacteremia cases were catheter-related bloodstream infections. On multivariate analysis, ICU admission prior to bacteremia episode and neutropenia were the major risk factors associated with mortality. S. maltophilia was the most susceptible to trimethoprim and sulfamethoxazole (TMP/SMX, 94.1%), followed by levofloxacin (85.7%). The overall mortality rate within seven days of S. maltophilia bacteremia diagnosis was 33.8%.
S. maltophilia bacteremia is a devastating emerging infection associated with high mortality among hospitalized children. Therefore, early diagnosis and prompt management based on local susceptibility data are crucial. Various risk factors, especially ICU admission prior to bacteremia episode and neutropenia, are associated with S. maltophilia bacteremia mortality.
嗜麦芽窄食单胞菌(S. maltophilia)是一种机会致病菌和医院获得性病原体,可导致侵袭性和致命感染,特别是在住院和免疫功能低下的患者中。然而,对于小儿嗜麦芽窄食单胞菌菌血症的影响知之甚少。因此,我们旨在确定小儿嗜麦芽窄食单胞菌菌血症患者死亡的危险因素、嗜麦芽窄食单胞菌对抗生素的敏感性以及死亡率。
我们通过在 2007 年 1 月至 2018 年 12 月期间从住院儿科患者(年龄 1-14 岁)的微生物实验室数据库中确定所有嗜麦芽窄食单胞菌阳性血培养物,进行了回顾性队列研究。在确定患有嗜麦芽窄食单胞菌菌血症的患者后,回顾病历以了解菌血症诊断后 7 天内的人口统计学、临床数据和结局。使用单变量和多变量分析确定与嗜麦芽窄食单胞菌菌血症患者死亡相关的危险因素。
共确定了 68 例小儿嗜麦芽窄食单胞菌菌血症患者。所有感染均为医院获得性感染,(88.2%)菌血症病例为导管相关血流感染。多变量分析表明,菌血症发作前入住 ICU 和中性粒细胞减少是与死亡相关的主要危险因素。嗜麦芽窄食单胞菌对甲氧苄啶和磺胺甲噁唑(TMP/SMX,94.1%)最敏感,其次是左氧氟沙星(85.7%)。嗜麦芽窄食单胞菌菌血症诊断后 7 天内的总死亡率为 33.8%。
嗜麦芽窄食单胞菌菌血症是一种破坏性的新兴感染,与住院儿童的高死亡率相关。因此,根据当地药敏数据进行早期诊断和及时治疗至关重要。各种危险因素,特别是菌血症发作前入住 ICU 和中性粒细胞减少,与嗜麦芽窄食单胞菌菌血症死亡率相关。